日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

To generate functional anti-protease-activated receptor-4 (PAR4), a G protein-coupled receptor, antibodies through PAR4-mRNA-LNP immunization

为了生成功能性抗蛋白酶激活受体4 (PAR4)（一种G蛋白偶联受体）抗体，可通过PAR4-mRNA-LNP免疫接种实现。

期刊:NPJ Vaccines
影响因子:6.5
doi:10.1038/s41541-025-01283-x
Liu, En-Shuo; Ho, Kai-Wen; Wu, Chin-Chung; Fan, Hsiao-Li; Wang, Ting-Yu; Hsieh, Yuan-Chin; Huang, Bo-Cheng; Hong, Shih-Ting; Liao, Tzu-Yi; Liu, Yen-Ling; Chen, Yu-Tung; Lee, Chia-Ching; Chen, Chiao-Yun; Lin, Chih-Lung; Cheng, Tian-Lu
PAR4
信号转导
免疫/内分泌
发表日期：2025
文献求助 收藏

Genetically engineered secretory horseradish peroxidase is a sensitive, stable, and affordable non-lytic reporter gene system for real-time promoter activity management.

基因工程分泌型辣根过氧化物酶是一种灵敏、稳定且价格低廉的非裂解性报告基因系统，可用于实时启动子活性管理

期刊:Journal of Biological Engineering
影响因子:6.5
doi:10.1186/s13036-025-00508-w
Chang Mu-Shen, Lee Chia-Yi, Chang Yu-Yen, Li Pin-Jie, Wu Hsin-Yu, Liu En-Shuo, Huang Hsin-Kai, Lin Wen-Wei
其它
发表日期：2025
文献求助 收藏

Spatial-hindrance-based pro-Adalimumab prevents anti-idiotypic antibody interference in pharmacokinetic and therapeutic efficacy.

基于空间阻碍的pro-Adalimumab可防止抗独特型抗体干扰药代动力学和治疗效果

期刊:Bioengineering & Translational Medicine
影响因子:5.7
doi:10.1002/btm2.70015
Huang Bo-Cheng, Chen Yu-Tung, Lu Yun-Chi, Ho Kai-Wen, Hong Shih-Ting, Liao Tzu-Yi, Wu I-Hsuan, Liu En-Shuo, Liao Jun-Min, Chen Fang-Ming, Li Chia-Ching, Chuang Chih-Hung, Chen Chiao-Yun, Cheng Tian-Lu
免疫/内分泌
发表日期：2025
文献求助 收藏

Strategies for Non-Covalent Attachment of Antibodies to PEGylated Nanoparticles for Targeted Drug Delivery

用于靶向药物递送的抗体与聚乙二醇化纳米颗粒的非共价连接策略

期刊:International Journal of Nanomedicine
影响因子:6.5
doi:10.2147/IJN.S479270
Ho, Kai-Wen; Liu, Yen-Ling; Liao, Tzu-Yi; Liu, En-Shuo; Cheng, Tian-Lu
发表日期：2024
文献求助 收藏

Fibrinogen-Like Protein 1 Serves as an Anti-Inflammatory Agent for Collagen-Induced Arthritis Therapy in Mice.

纤维蛋白原样蛋白 1 可作为抗炎剂用于治疗小鼠胶原蛋白诱导的关节炎

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2021.767868
Lin Wen-Wei, Ho Kai-Wen, Su Hsiang-Han, Fang Tien-Fang, Tzou Shey-Cherng, Chen I-Ju, Lu Yun-Chi, Chang Mu-Shen, Tsai Yun-Chen, Liu En-Shuo, Su Yu-Cheng, Wang Yen-Tseng, Cheng Tian-Lu, Huang Hsin-Kai
炎症/感染
关节炎
炎症
发表日期：2021
文献求助 收藏

Selective activation of pro-anti-IL-1β antibody enhances specificity for autoinflammatory disorder therapy.

选择性激活促抗IL-1β抗体可增强自身炎症性疾病治疗的特异性

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-021-94298-y
Lin Wen-Wei, Lu Yun-Chi, Huang Bo-Cheng, Chuang Chih-Hung, Cheng Yi-An, Chen I-Ju, Liu Hui-Ju, Ho Kai-Wen, Liao Tzu-Yi, Liu En-Shuo, Wu Ting-Yi, Chang Long-Sen, Hong Shih-Ting, Cheng Tian-Lu
免疫/内分泌
炎症
发表日期：2021
文献求助 收藏

Humanized bispecific antibody (mPEG × HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer

人源化双特异性抗体（mPEG × HER2）可快速赋予聚乙二醇化纳米颗粒肿瘤特异性，用于乳腺癌的多模态成像

期刊:Journal of Nanobiotechnology
影响因子:12.6
doi:10.1186/s12951-020-00680-9
Cheng, Yi-An; Wu, Tung-Ho; Wang, Yun-Ming; Cheng, Tian-Lu; Chen, I-Ju; Lu, Yun-Chi; Chuang, Kuo-Hsiang; Wang, Chih-Kuang; Chen, Chiao-Yun; Lin, Rui-An; Chen, Huei-Jen; Liao, Tzu-Yi; Liu, En-Shuo; Chen, Fang-Ming
肿瘤
HER2
肿瘤免疫
乳腺癌
Human
发表日期：2020
文献求助 收藏